Bactericidal Potency and Extended Serum Life of Stereo-Chemically Engineered Peptides Against Mycobacterium
PK Hazam, A Singh, N Chaudhary… - International Journal of …, 2019 - Springer
Tuberculosis is one of the leading causes of death, with an annual mortality rate of 2 million.
The present treatment regimen for Mycobacterium species is strenuous, extending up to 12 …
The present treatment regimen for Mycobacterium species is strenuous, extending up to 12 …
Mecanismos moleculares y manejo clínico de la tuberculosis resistente a fármacos:¿ Un enemigo invencible?
KMV Ramírez, MJD Morocho, IMG Gusqui… - … de Farmacología y …, 2019 - saber.ucv.ve
La Tuberculosis resistente a fármacos es un problema desalud pública mundial y es uno de
los principales obstáculospara alcanzar los objetivos de control planteados a nivelglobal …
los principales obstáculospara alcanzar los objetivos de control planteados a nivelglobal …
A sensitive EZMTT method provides microscale, quantitative and high-throughput evaluation of drug efficacy in the treatment of Mycobacterium tuberculosis infectious …
L Xie, Z Chen, W Liu, D Gu, Y Yu, X Chen, Y Wu… - Journal of …, 2021 - Elsevier
Drug resistance has become a serious public health problem in mycobacterial infectious
diseases. Here, we investigated a water soluble tetrazolium salt (EZMTT)-based detection …
diseases. Here, we investigated a water soluble tetrazolium salt (EZMTT)-based detection …